论文部分内容阅读
目的:观察门冬氨酸钾镁对72例老年室性心律失常的治疗效果。方法:102例老年室性心律失常患者分为对照组30例,单纯用心律平150mg 3次/日;治疗组72例,用门冬氨酸钾镁50～100ml加入葡萄糖水200～500ml中静脉滴注,治疗组根据有无心衰分为心衰组40例,无心衰组32例。治疗前后各组均作动态心电图,分别作疗效评价。结果:治疗组有效率81.9％,对照组有效率63.3％(P<0.05)差异有显著性,心衰组显效率45％,无心衰组显效率21.9％(P<0.05)差异有显著性。结论:门冬氨酸钾镁有确切抗室性心律失常作用,尤其适用于心衰患者。
Objective: To observe the therapeutic effect of potassium magnesium aspartate in 72 elderly patients with ventricular arrhythmias. Methods: 102 cases of elderly patients with ventricular arrhythmias were divided into control group of 30 cases, simple use of rhythm of flatulence 150mg 3 times / day; treatment group of 72 cases, with potassium magnesium aspartate 50 ~ 100ml added glucose water 200 ~ 500ml medium vein Instillation, treatment group according to the presence or absence of heart failure divided into heart failure group 40 cases, no heart failure group 32 cases. Before and after treatment, all groups were given dynamic electrocardiogram, respectively, for evaluation of curative effect. Results: The effective rate was 81.9% in the treatment group and 63.3% in the control group (P <0.05). The difference was significant between the effective rate of 45% in the heart failure group and 21.9% in the no-heart failure group (P <0.05) . Conclusion: Potassium magnesium aspartate has definite anti-ventricular arrhythmia, especially for patients with heart failure.